Myomo, Inc. (AMEX:MYO) Q4 2022 Earnings Call Transcript

Paul Gudonis: Yes, international was about 11% of revenues in the fourth quarter. Direct billing channel was about 73% in the U.S.. And then VA revenues were a record, about 11% of revenue.

Paul Lowry: All right. Thank you.

Operator: This will conclude our question-and-answer session. I would like to turn the conference back over to Paul Gudonis for any closing remarks.

Paul Gudonis: Thank you, operator. While, in closing, I’ll just highlight what makes Myomo a special company. We have a large unmet market opportunity to assist individuals with upper extremity paralysis. Our MyoPro pipeline is gaining traction with a record number of patients in the process of obtaining one. We’ve got more doctors prescribing it for their patients and more rehab therapists being trained on how to work with new MyoPro users. We’ve developed a track record of obtaining reimbursement from a set of payers here in the U.S. and several international markets and we’re closer obtaining coverage for Medicare Part B patients. And we continue to innovate not only in our product design, but also in our business processes to basically operate more efficiently as we scale the business. So thank you all for your continued interest in Myomo and have a good day.

Operator: The conference is now concluded. Thank you for attending today’s presentation. You may now disconnect.